back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-13 11:20 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-14,914 vol |
2,486 | |
| Filed 2024-01-13 11:20 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-64,285 vol |
10,715 | |
| Filed 2023-08-04 17:37 Tx date 2023-08-04 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+17,400 vol |
17,400 | |
| Filed 2023-08-04 17:34 Tx date 2023-07-15 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-21 18:11 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2023-07-21 18:09 Tx date 2023-07-15 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-21 14:58 Tx date 2022-12-16 |
$TMD
Titan Medical Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
$253,689
+362,413 vol $0.70 each |
993,912 | |
| Filed 2022-07-15 17:05 Tx date 2022-07-12 |
$TMD
Titan Medical Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,647
+148,505 vol $0.57 each |
548,505 | |
| Filed 2022-07-15 17:03 Tx date 2022-07-12 |
$TMD
Titan Medical Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
$177,760
+311,861 vol $0.57 each |
631,499 | |
| Filed 2022-04-06 16:01 Tx date 2022-04-04 |
$TMD
Titan Medical Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
$37,500
+69,638 vol $0.54 each |
319,638 | |
| Filed 2021-08-24 11:36 Tx date 2021-08-20 |
$TMD
Titan Medical Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$632,000
+400,000 vol $1.58 each |
400,000 | |
| Filed 2021-08-24 11:33 Tx date 2021-07-12 |
$TMD
Titan Medical Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-24 11:31 Tx date 2021-08-20 |
$TMD
Titan Medical Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
$380,000
+250,000 vol $1.52 each |
250,000 | |
| Filed 2021-08-24 11:21 Tx date 2021-07-12 |
$TMD
Titan Medical Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-04 15:31 Tx date 2020-09-02 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+12,500 vol $0.90 each |
82,500 | |
| Filed 2020-09-04 15:30 Tx date 2020-09-01 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
70,000 | |
| Filed 2020-09-04 15:28 Tx date 2020-09-01 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
56 - Grant of rights
|
+57,375 vol |
57,375 | |
| Filed 2020-09-04 15:23 Tx date 2020-06-25 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-04 15:17 Tx date 2020-06-25 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-04 15:15 Tx date 2020-09-01 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,471
+133,875 vol $0.87 each |
483,875 | |
| Filed 2020-07-09 13:29 Tx date 2020-06-25 |
$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$13,000
+10,000 vol $1.30 each |
10,000 | |
| Filed 2020-07-09 13:28 Tx date 2020-06-25 |
$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-09 13:22 Tx date 2020-06-25 |
$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$350,000
+350,000 vol $1.00 each |
350,000 | |
| Filed 2020-07-09 13:21 Tx date 2020-06-25 |
$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-09 13:20 Tx date 2020-06-25 |
$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+20,000 vol |
20,000 | |
| Filed 2020-07-09 13:17 Tx date 2020-06-25 |
$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-19 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$299.52
+192 vol $1.56 each |
24,550 | |
| Filed 2019-02-19 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$299.46
+186 vol $1.61 each |
24,358 | |
| Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+765 vol $1.65 each |
24,172 | |
| Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+836 vol $1.51 each |
23,407 | |
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+836 vol $1.51 each |
22,571 | |
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+836 vol $1.51 each |
||
| Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+495 vol $2.55 each |
21,735 | |
| Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,263
+453 vol $2.79 each |
21,240 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,263
+488 vol $2.59 each |
20,787 | |
| Filed 2018-07-19 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,261
+530 vol $2.38 each |
20,299 | |
| Filed 2018-07-05 Tx date 2018-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-3,582 vol |
23,216 | |
| Filed 2018-07-05 Tx date 2018-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,993
+3,582 vol $2.79 each |
19,769 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,263
+547 vol $2.31 each |
16,187 | |
| Filed 2018-05-21 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+425 vol $2.97 each |
15,640 | |
| Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,263
+353 vol $3.58 each |
15,215 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$17,025
+4,769 vol $3.57 each |
||
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,769 vol |
11,280 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,582 vol |
14,862 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-4,769 vol |
||
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-4,769 vol |
43,678 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,582 vol |
40,096 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+22,213 vol |
48,447 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$358,295
+101,500 vol $3.53 each |
226,544 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,206
+357 vol $3.38 each |
6,511 | |
| Filed 2018-02-20 Tx date 2018-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,207
+353 vol $3.42 each |
6,154 | |
| Filed 2018-01-17 Tx date 2018-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,206
+326 vol $3.70 each |
5,801 | |
| Filed 2017-12-19 Tx date 2017-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,207
+305 vol $3.96 each |
5,475 | |
| Filed 2017-11-17 Tx date 2017-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,208
+313 vol $3.86 each |
5,170 | |
| Filed 2017-10-20 Tx date 2017-10-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,206
+320 vol $3.77 each |
4,857 | |
| Filed 2017-09-25 Tx date 2017-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+16,052 vol |
26,798 | |
| Filed 2017-09-19 Tx date 2017-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,205
+300 vol $4.02 each |
4,537 | |
| Filed 2017-08-18 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,206
+264 vol $4.57 each |
4,237 | |
| Filed 2017-07-20 Tx date 2017-07-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,209
+263 vol $4.60 each |
3,973 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$602.88
+128 vol $4.71 each |
3,710 | |
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+19,070 vol |
26,234 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$442,056
+87,363 vol $5.06 each |
125,044 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,582 vol |
||
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,582 vol |
7,164 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,582 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,582 vol |
3,582 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,582 vol |
7,164 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,582 vol |
3,582 | |
| Filed 2017-04-03 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+10,746 vol |
10,746 | |
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+10,746 vol |
10,746 | |
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$195,187
+37,681 vol $5.18 each |
37,681 | |
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
146,637 | |
| Filed 2016-03-24 Tx date 2016-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
+28,912 vol |
90,549 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
78,046 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
61,637 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,341 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
19,652 | ||
| Filed 2016-02-29 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+95,758 vol |
95,758 | |
| Filed 2016-02-29 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+90,758 vol |
||
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
97 - Other
|
-6 vol |
61,637 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-240,415.45
-46,145 vol $5.21 each |
73,046 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$18,228
+6,076 vol $3.00 each |
19,652 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Lemieux, Stephen
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-6,076 vol |
0 |